Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Radient Technologies Inc V.RTI.H

Alternate Symbol(s):  RDDTF

Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.


TSXV:RTI.H - Post by User

Comment by lscfaon Dec 25, 2020 3:06pm
197 Views
Post# 32182844

RE:RE:i wish

RE:RE:i wish

Reviewing the documentation between the applicant and the patent office (see link below) reveals some things of interest.

 

The patent application was rejected by the US patent office multiple times between 2014 and 2020. The applicant kept submitting amendments and arguments why the patent should be allowed. An amended version of the patent was finally allowed based in part on the applicant’s argument that:

 

"Nowhere do the cited references teach or suggest to extract cannabinoids using liquid CO2 under subcritical conditions of temperature and pressure, nor do the cited references teach or suggest to reduce the temperature and/or pressure to separate the cannabinoids from the CO2." (June 26, 2020)

 

It appears that the role of a patent examiner is to query the patent record using key words like THC, CBD, hemp, delta 9, cannabinoids, carbon dioxide, subcritical, etc. to determine if an earlier version of the present patent application exists. Examiners do not make judgement calls on what can be reasonably inferred from a patent. That’s left to the courts.

 

Prior patents may not have explicitly stated that one must reduce the temperature and/or pressure after using same to extract molecules from plant materials but it is common sense that it is a necessary step in the process. I believe the courts will conclude the same thing.


 

 

 

 

https://portal.uspto.gov/pair/PublicPair

 

Application no. 14/276,165


 

<< Previous
Bullboard Posts
Next >>